Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia

American Journal of Clinical Pathology

Volumn 127, Issue 3, 2007, Pages 429-433

  Janatpour, Kim A ^a   Gosselin, Robert C ^a   Dager, William E ^a   Lee, Andrew ^a   Owings, John T ^b   Zhou, Jufen ^b   Wun, Ted ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

ELISA; Enzyme linked immunosorbent assay; Heparin; Optical density; Thrombocytopenia; Thrombosis

Indexed keywords

HEPARIN PLATELET FACTOR 4 ANTIBODY; ANTICOAGULANT AGENT; AUTOANTIBODY; HEPARIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PRIORITY JOURNAL; PROBABILITY SAMPLE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ANALYSIS OF VARIANCE; BLOOD; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; METHODOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; STATISTICS; THROMBOCYTOPENIA; THROMBOSIS;

ANALYSIS OF VARIANCE; ANTICOAGULANTS; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPARIN; HUMANS; PLATELET FACTOR 4; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 34247844418     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/RPE753J4PMG9773Q     Document Type: Article

References (9)

1. Greinacher A, Warkentin TE. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update. Thromb Res. 2006;118:165-176.
2. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [published correction appears in Chest. 2005;127:416]. Chest. 2004;126(3 suppl):311S-337S.
3. Davoren A, Aster RH. Heparin-induced thrombocytopenia and thrombosis. Am J Hematol. 2006;81:36-44.
4. Zwicker JI, Uhl L, Huang WY, et al. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost. 2004;2:2133-2137.
5. Warkentin TE, Heddle NM. Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep. 2003;2:148-157.
6. Chong BH, Chong JH. Heparin-induced thrombocytopenia. Expert Rev Cardiovasc Ther. 2004;2:547-559.
7. Lo GK, Juhl D, Warkentin TE, et al. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4:759-765.
8. Pouplard C, Amiral J, Borg JY, et al. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol. 1999;111:700-706.
9. Wells PS, Owen C, Doucette S, et al. Does this patient have deep vein thrombosis? JAMA. 2006;295:199-207.